Literature DB >> 10771132

Induction of apoptosis in caco-2 cells by wheat gliadin peptides.

C Giovannini1, M Sanchez, E Straface, B Scazzocchio, M Silano, M De Vincenzi.   

Abstract

Recent experimental evidence suggests that enterocyte apoptosis is greater than hitherto assumed and may be responsible for villous atrophy in coeliac disease. We have previously demonstrated that a small peptide (M.W. 1157.5 Da), identified as the sequence H(2)N-gln-gln-pro-gln-asp-ala-val-gln-pro-phe-COOH from durum wheat gliadin, is able to prevent K 562 (S) cell agglutination induced by the peptic-tryptic digests (PT) of prolamin fractions from the cereals which are not tolerated in coeliac disease (i.e. bread wheat, rye, barley and possibly oats), and toxic A-gliadin peptides in coeliac disease. In the present study we have investigated the effects of the bread wheat gliadin digest (PT) on apoptosis of Caco-2 cells and whether the '1157.5' Da peptide may in any way interfere with them. We evaluated both earlier biochemical and later morphological nuclear apoptotic events in the human colon adenocarcinoma cell line Caco-2. After 48 h exposure to the PT gliadin digest and the '1157.5' Da peptide, apoptosis was detected both for the early-stage apoptotic cells (adherent cells) and the late-stage apoptotic ones (detached cells which were floating in the culture medium). Exposure to the PT gliadin digest resulted in a high percentage of adherent cells that underwent cell death by apoptosis (about 30%), independent of the concentration range used; while the presence in the culture medium of peptide '1157.5' Da determined complete inhibition of cell death. On the other hand, morphological nuclear modifications observed in the floating cells showed a difference in the rate of the apoptosis dependent on the PT concentration, with partial protection in the presence of the peptide. These findings show an action of bread wheat gliadin peptides leading to cell death by apoptosis in the Caco-2 cell line and that the '1157.5' Da peptide is capable of preventing such an effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771132     DOI: 10.1016/s0300-483x(99)00223-1

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  15 in total

1.  Getting to grips with gluten.

Authors:  S N McAdam; L M Sollid
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  Is gluten a cause of gastrointestinal symptoms in people without celiac disease?

Authors:  Jessica R Biesiekierski; Jane G Muir; Peter R Gibson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

3.  Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.

Authors:  Maria Vittoria Barone; Anna Gimigliano; Gabriella Castoria; Giovanni Paolella; Francesco Maurano; Franco Paparo; Maria Maglio; Alba Mineo; Erasmo Miele; Merlin Nanayakkara; Riccardo Troncone; Salvatore Auricchio
Journal:  Gut       Date:  2006-08-04       Impact factor: 23.059

4.  Alendronate-induced unmasking or deterioration of coeliac disease: a case series.

Authors:  B G A Stuckey; R Sallie
Journal:  Osteoporos Int       Date:  2014-10-28       Impact factor: 4.507

5.  Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis.

Authors:  C Bojarski; A H Gitter; K Bendfeldt; J Mankertz; H Schmitz; S Wagner; M Fromm; J D Schulzke
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

6.  A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity.

Authors:  W Sakly; V Thomas; G Quash; S El Alaoui
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

7.  Gliadins induce TNFalpha production through cAMP-dependent protein kinase A activation in intestinal cells (Caco-2).

Authors:  José Moisés Laparra Llopis; Yolanda Sanz Herranz
Journal:  J Physiol Biochem       Date:  2010-06-01       Impact factor: 4.158

8.  Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.

Authors:  D Bernardo; J A Garrote; Y Allegretti; A León; E Gómez; J F Bermejo-Martin; C Calvo; S Riestra; L Fernández-Salazar; A Blanco-Quirós; F Chirdo; E Arranz
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

9.  Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation.

Authors:  Maria Vittoria Barone; Merlin Nanayakkara; Giovanni Paolella; Mariantonia Maglio; Virginia Vitale; Raffaele Troiano; Maria Teresa Silvia Ribecco; Giuliana Lania; Delia Zanzi; Sara Santagata; Renata Auricchio; Riccardo Troncone; Salvatore Auricchio
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

10.  Chickpea protein hydrolysate as a substitute for serum in cell culture.

Authors:  Julio Girón-Calle; Javier Vioque; Justo Pedroche; Manuel Alaiz; María M Yust; Cristina Megías; Francisco Millán
Journal:  Cytotechnology       Date:  2008-10-07       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.